The Role of Cytokines in Autoimmune Diseases: Pathogenesis and Therapeutic Implications
Abstract
Autoimmune diseases are characterized by the immune system's aberrant response against the body's own tissues, leading to chronic inflammation and tissue damage. Cytokines, as critical mediators of immune responses, play a pivotal role in the development and progression of autoimmune disorders. These small signaling proteins regulate the activation, differentiation, and proliferation of immune cells, and their dysregulation can trigger or exacerbate autoimmunity. Pro-inflammatory cytokines such as tumor necrosis factor-alpha (TNF-α), interleukin-1 (IL-1), IL-6, IL-17, and interferon-gamma (IFN-γ) have been found to be highly expressed in several autoimmune diseases, including rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis, and inflammatory bowel disease. Conversely, anti-inflammatory cytokines like IL-10 and transforming growth factor-beta (TGF-β) attempt to counterbalance this response but are often insufficient to control disease progression. Understanding the specific cytokine profiles and their interactions provides valuable insight into the pathogenesis of these diseases. Moreover, targeting cytokines has become a promising therapeutic approach. Biologic agents such as monoclonal antibodies and receptor antagonists have been developed to inhibit specific cytokines, significantly improving clinical outcomes in many patients. However, challenges remain, including the risk of immunosuppression and variability in patient response. Future research is focused on identifying more precise cytokine targets and developing personalized cytokine-based therapies. In conclusion, cytokines play a central role in the pathogenesis of autoimmune diseases, and modulating their activity holds great potential for innovative and effective treatments.
References
SG Utkurovna and KF Farkhodovna, "Features of immune mechanisms in the development of pathological processes," Достижения науки и …, 2022. [Online]. Available: cyberleninka.ru
Z. X. Xiao, J. S. Miller, and S. G. Zheng, "An updated advance of autoantibodies in autoimmune diseases," Autoimmunity Reviews, 2021. [Online]. Available: [HTML]
X. Yu, J. Wax, G. Riemekasten, and F. Petersen, "Functional autoantibodies: Definition, mechanisms, origin and contributions to autoimmune and non-autoimmune disorders," Autoimmunity Reviews, 2023. [Online]. Available: [HTML]
E. Mezgebu, A. Aliy, and T. Worku, "Autoimmunity and immune tolerance: A review," Microbiol. Res. Int., 2023. [Online]. Available: netjournals.org
H. Jin and H. Arase, "Neoself Antigens Presented on MHC Class II Molecules in Autoimmune Diseases," Basic Immunology and Its Clinical Application, 2024. [Online]. Available: [HTML]
V. Salvi, V. Gianello, L. Tiberio, S. Sozzani et al., "Cytokine Targeting by miRNAs in Autoimmune Diseases," 2019. [Online]. Available: ncbi.nlm.nih.gov
L. Szewczak and K. Donskow-Łysoniewska, "Cytokines and Transgenic Matrix in Autoimmune Diseases: Similarities and Differences," 2020. [Online]. Available: ncbi.nlm.nih.gov
N. M. de Gruijter and B. Jebson, "Cytokine production by human B cells: role in health and autoimmune disease," Clinical and Experimental Immunology, vol. 2022. [Online]. Available: oup.com
A. Cheng and S. M. Holland, "Anti-cytokine autoantibodies: mechanistic insights and disease associations," Nature Reviews Immunology, 2024. [Online]. Available: researchgate.net
O. Ciesielski, M. Biesiekierska, B. Panthu, and others, "Citrullination in the pathology of inflammatory and autoimmune disorders: recent advances and future perspectives," Cellular and Molecular Immunology, vol. 19, no. 1, pp. 1-11, 2022. [Online]. Available: springer.com
C. M. Li and Z. Chen, "Autoimmunity as an etiological factor of cancer: the transformative potential of chronic type 2 inflammation," Frontiers in Cell and Developmental Biology, 2021. [Online]. Available: frontiersin.org
J. Li, L. Li, Y. Wang, G. Huang, X. Li, and Z. Xie, "Insights into the role of DNA methylation in immune cell development and autoimmune disease," Frontiers in Cell and Developmental Biology, vol. 2021. [Online]. Available: frontiersin.org
J. Liu, H. Zhang, Y. Su, and B. Zhang, "Application and prospect of targeting innate immune sensors in the treatment of autoimmune diseases," Cell & Bioscience, 2022. [Online]. Available: springer.com
C. Dong, "Cytokine regulation and function in T cells," Annual Review of Immunology, 2021. [Online]. Available: [HTML]
M. Edwards and L. Brockmann, "Microbiota-dependent modulation of intestinal anti-inflammatory CD4+ T cell responses," Seminars in Immunopathology, 2025. [Online]. Available: [HTML]
C. H. Koh, S. Lee, M. Kwak, B. S. Kim, et al., "CD8 T-cell subsets: heterogeneity, functions, and therapeutic potential," Experimental & Molecular Medicine, vol. 55, no. 3, 2023. [Online]. Available: nature.com
S. Noor, A. Fatima, I. Fatima, and A. Javed, "5 Antigen-Antibody Interaction in Cell Signaling," in Cell Signaling: Interplay …, 2025. [Online]. Available: [HTML]
J. H. Kim, K. J. Lee, and S. W. Lee, "Cancer immunotherapy with T-cell targeting cytokines: IL-2 and IL-7," BMB Reports, 2021. [Online]. Available: nih.gov
B. Toledo, L. Zhu Chen, M. Paniagua-Sancho, et al., "Deciphering the performance of macrophages in tumour microenvironment: a call for precision immunotherapy," Journal of Hematology & Oncology, vol. 17, no. 1, 2024. [Online]. Available: springer.com
A. Korta, J. Kula, and K. Gomułka, "The role of IL-23 in the pathogenesis and therapy of inflammatory bowel disease," International Journal of Molecular Sciences, 2023. [Online]. Available: mdpi.com
C. Leon, A. Tokarev, A. Bouchnita, and V. Volpert, "Modelling of the innate and adaptive immune response to SARS viral infection, cytokine storm and vaccination," Vaccines, 2023. [Online]. Available: mdpi.com
A. F. Salvador, K. A. de Lima, and J. Kipnis, "Neuromodulation by the immune system: a focus on cytokines," Nature Reviews Immunology, 2021. [Online]. Available: google.com
T. Hussain, G. Murtaza, and D. H. Kalhoro, "Understanding the immune system in fetal protection and maternal infections during pregnancy," Journal of …, vol. 2022. [Online]. Available: Wiley Online Library
C. Papanikolaou, V. Rapti, D. Stellas, D. T. Stefanou, "Delineating the SARS-CoV-2 induced interplay between the host immune system and the DNA damage response network," Vaccines, 2022. [Online]. Available: mdpi.com
C. Agrati, B. Bartolini, V. Bordoni, F. Locatelli, et al., "Emerging viral infections in immunocompromised patients: A great challenge to better define the role of immune response," Frontiers in …, 2023. [Online]. Available: frontiersin.org
M. S. Qudus, M. Tian, S. Sirajuddin, and S. Liu, "The roles of critical pro‐inflammatory cytokines in the drive of cytokine storm during SARS‐CoV‐2 infection," Journal of Medical …, 2023. [Online]. Available: wiley.com
M. Jamal, H. I. Bangash, M. Habiba, Y. Lei, T. Xie, J. Sun, et al., "Immune dysregulation and system pathology in COVID-19," Virulence, vol. 12, no. 1, pp. 1-15, 2021. [Online]. Available: tandfonline.com
M. Aliyu, F. T. Zohora, A. U. Anka, K. Ali, S. Maleknia, and others, "Interleukin-6 cytokine: An overview of the immune regulation, immune dysregulation, and therapeutic approach," International Journal, vol. 2022. [Online]. Available: Elsevier
L. Y. R. Wong and S. Perlman, "Immune dysregulation and immunopathology induced by SARS-CoV-2 and related coronaviruses—are we our own worst enemy?," Nature Reviews Immunology, 2022. [Online]. Available: nature.com
R. Pasrija and M. Naime, "The deregulated immune reaction and cytokines release storm (CRS) in COVID-19 disease," International Immunopharmacology, 2021. [Online]. Available: nih.gov
A. Zawadzka, M. Cieślik, and A. Adamczyk, "The role of maternal immune activation in the pathogenesis of autism: a review of the evidence, proposed mechanisms and implications for treatment," International Journal of Molecular Sciences, vol. 22, no. 2021, 2021. [Online]. Available: mdpi.com
J. L. Boechat, I. Chora, A. Morais, and L. Delgado, "The immune response to SARS-CoV-2 and COVID-19 immunopathology–current perspectives," Pulmonology, 2021. [Online]. Available: sciencedirect.com
L. M. Khosroshahi and N. Rezaei, "Dysregulation of the immune response in coronavirus disease 2019," Cell Biology International, 2021. [Online]. Available: nih.gov
N. Azhar Abdulmuttaleb, M. Q. Mohammed, and O. A. Mohsein, "The impact of adipocytokines on thyroid function and obesity: A narrative review," Development, vol. 8, p. 9.
A. A. Rabaan, S. H. Al-Ahmed, M. A. Garout, and A. M. Al-Qaaneh, "Immunological factors influencing pathogenesis in patients with COVID-19: a review on viral dissemination, immunotherapeutic options to counter cytokine," Pathogens, vol. 10, no. 3, 2021. [Online]. Available: mdpi.com
P. Wójcik, A. Gęgotek, N. Žarković, et al., "Oxidative stress and lipid mediators modulate immune cell functions in autoimmune diseases," International Journal of …, 2021. [Online]. Available: mdpi.com
U. C. Kucuksezer, E. Aktas Cetin, and F. Esen, "The role of natural killer cells in autoimmune diseases," Frontiers in …, 2021. [Online]. Available: frontiersin.org
G. Cavalli, S. Colafrancesco, G. Emmi, M. Imazio, et al., "Interleukin 1α: a comprehensive review on the role of IL-1α in the pathogenesis and treatment of autoimmune and inflammatory diseases," Autoimmunity, vol. 2021. [Online]. Available: sciencedirect.com
K. D. Moudgil and S. H. Venkatesha, "The anti-inflammatory and immunomodulatory activities of natural products to control autoimmune inflammation," International Journal of Molecular Sciences, 2022. [Online]. Available: mdpi.com
Y. Xiang, M. Zhang, D. Jiang, Q. Su, et al., "The role of inflammation in autoimmune disease: a therapeutic target," Frontiers in Immunology, 2023. [Online]. Available: frontiersin.org
E. M. El-Shebiny, E. S. Zahran, and S. A. Shoeib, "Bridging autoinflammatory and autoimmune diseases," The Egyptian Journal of …, vol. XX, no. YY, pp. ZZ–ZZ, 2021. [Online]. Available: springer.com
V. Raghuvanshi and A. Kumar, "From Bronchial Asthma to Tuberculosis: Unravelling the Cytokine-Macrophage Axis in Diverse Diseases," 2024. [Online]. Available: suntextreviews.org
F. Xiao, X. Tang, K. Ma, and X. Dai, "Advances in organ-specific autoimmune response: from basics to clinics," Frontiers in Immunology, 2024. [Online]. Available: frontiersin.org
S. Ali, S. Sangwan, P. Srivastava, and S. Khan, "From Bronchial Asthma to Tuberculosis: Unravelling the Cytokine-Macrophage Axis in Diverse Diseases," International Journal of …, 2024. [Online]. Available: aditum.org
A. Abdulhussien, Z. M. Farhan, and O. A. Mohsein, "The Clinico-Pathological Role of Horizontal Gene Transfer in the Ability of Pseudomonas Aeruginosa to Cause Disease in Lung Tissue," European Journal of Medical and Health Research, vol. 3, no. 1, pp. 27–34, 2025.
K. Akabane and K. Murakami, "Gateway reflexes are neural circuits that establish the gateway of immune cells to regulate tissue specific inflammation," Expert Opinion on …, vol. 2023. [Online]. Available: [HTML]
C. Graves, E. Babikow, and N. Ghaltakhchyan, "Immune dysregulation in the oral cavity during early SARS-CoV-2 infection," Journal of Dental Research, 2024. [Online]. Available: sagepub.com
A. S. Y. Khaja, N. K. Binsaleh, H. Qanash, H. Alshetaiwi, et al., "Dysregulation and therapeutic prospects of regulatory T cells in type 1 diabetes," Acta Diabetologica, 2025. [Online]. Available: [HTML]
V. Salvi, V. Gianello, L. Tiberio, S. Sozzani, et al., "Cytokine Targeting by miRNAs in Autoimmune Diseases," 2019. [Online]. Available: [PDF]
X. Chen, Y. Liu, Y. Gao, S. Shou, et al., "The roles of macrophage polarization in the host immune response to sepsis," International Immunopharmacology, 2021. [Online]. Available: [HTML]
K. Mortezaee and J. Majidpoor, "Roles for macrophage-polarizing interleukins in cancer immunity and immunotherapy," Cellular Oncology, 2022. [Online]. Available: [HTML]
J. Wang, S. Lu, F. Yang, Y. Guo, Z. Chen, N. Yu, and L. Yao, "The role of macrophage polarization and associated mechanisms in regulating the anti-inflammatory action of acupuncture: a literature review and perspectives," Chinese Medicine, vol. 16, no. 1, 2021. [Online]. Available: springer.com
C. Kerneur, C. E. Cano, and D. Olive, "Major pathways involved in macrophage polarization in cancer," Frontiers in Immunology, 2022. [Online]. Available: frontiersin.org
E. Deer, O. Herrock, N. Campbell, and D. Cornelius, "The role of immune cells and mediators in preeclampsia," Nature Reviews, 2023. [Online]. Available: nih.gov
K. M. Adusei, T. B. Ngo, and K. Sadtler, "T lymphocytes as critical mediators in tissue regeneration, fibrosis, and the foreign body response," Acta Biomaterialia, 2021. [Online]. Available: [HTML]
R. Chen, Z. Hao, Y. Wang, H. Zhu, and Y. Hu, "Mesenchymal stem cell–immune cell interaction and related modulations for bone tissue engineering," Stem Cells, vol. 2022. [Online]. Available: Wiley Online Library
A. Cioce, A. Cavani, C. Cattani, and F. Scopelliti, "Role of the skin immune system in wound healing," Cells, 2024. [Online]. Available: mdpi.com
V. Gouirand, I. Habrylo, and M. D. Rosenblum, "Regulatory T cells and inflammatory mediators in autoimmune disease," Journal of Investigative …, 2022. [Online]. Available: sciencedirect.com
S. Schülke, S. Gilles, A. C. Jirmo, et al., "Tissue‐specific antigen‐presenting cells contribute to distinct phenotypes of allergy," European Journal of …, 2023. [Online]. Available: wiley.com
O. Palomares, D. Elewaut, P. M. Irving, X. Jaumont, et al., "Regulatory T cells and immunoglobulin E: a new therapeutic link for autoimmunity?," Allergy, vol. 77, no. 2, pp. 123–134, 2022. [Online]. Available: wiley.com
M. Cutine, C. A. Bach, F. Veigas, J. P. Merlo, et al., "Tissue-specific control of galectin-1-driven circuits during inflammatory responses," 2021. [Online]. Available: conicet.gov.ar
J. Ham, W. Yang, and H. Y. Kim, "Tissue-specific metabolic reprogramming in innate lymphoid cells and its impact on disease," Immune Network, 2025. [Online]. Available: nih.gov
F. Yasmeen, R. H. Pirzada, B. Ahmad, and B. Choi, "Understanding autoimmunity: mechanisms, predisposing factors, and cytokine therapies," International Journal of …, 2024. [Online]. Available: mdpi.com
L. A. Ridgley, A. E. Anderson, and A. G. Pratt, "What are the dominant cytokines in early rheumatoid arthritis?," 2017. [Online]. Available: ncbi.nlm.nih.gov
H. Zhao, L. Wu, G. Yan, Y. Chen, and M. Zhou, "Inflammation and tumor progression: signaling pathways and targeted intervention," Signal Transduction and Targeted Therapy, vol. 6, no. 1, 2021. [Online]. Available: nature.com
K. K. Kim, A. Mahajan, K. Patel, S. Syed, et al., "Materials and cytokines in the healing of diabetic foot ulcers," Advanced Materials, vol. 2021. [Online]. Available: Wiley Online Library
S. Nirenjen, J. Narayanan, and T. Tamilanban, "Exploring the contribution of pro-inflammatory cytokines to impaired wound healing in diabetes," Frontiers in …, 2023. [Online]. Available: frontiersin.org
H. Mehralizadeh, A. Nazari, F. Oruji, and M. Roostaie, "Cytokine sustained delivery for cancer therapy; special focus on stem cell-and biomaterial-based delivery methods," Research and Practice, vol. 2023. [Online]. Available: Elsevier
M. Sami Shafiek, "The role of Cytokines in Influencing the Healing of Wounds: Mechanisms, Therapeutic Targets, and Advancements," Translational Health Sciences, 2025. [Online]. Available: ekb.eg
J. Blanco, A. García, L. Hermida-Nogueira, et al., "How to explain the beneficial effects of leukocyte‐and platelet‐rich fibrin," Periodontology, vol. 2025. [Online]. Available: Wiley Online Library
K. Sun, Y. Li, and J. Jin, "A double-edged sword of immuno-microenvironment in cardiac homeostasis and injury repair," Signal Transduction and Targeted Therapy, 2021. [Online]. Available: nature.com
N. K. Bhol, M. M. Bhanjadeo, A. K. Singh, and U. C. Dash, "The interplay between cytokines, inflammation, and antioxidants: Mechanistic insights and therapeutic potentials of various antioxidants and anti-cytokine …," Biomedicine & …, 2024. [Online]. Available: sciencedirect.com
Y. Liu, H. Liu, Z. Li, H. Fan, X. Yan, X. Liu, and J. Xuan, "The Release of Peripheral Immune Inflammatory Cytokines Promote an Inflammatory Cascade in PCOS Patients via Altering the Follicular Microenvironment," Frontiers in …, 2021. [Online]. Available: frontiersin.org
N. Zotova, Y. Zhuravleva, and V. Chereshnev, "Acute and chronic systemic inflammation: features and differences in the pathogenesis, and integral criteria for verification and differentiation," International Journal of …, 2023. [Online]. Available: mdpi.com
E. Gusev, L. Solomatina, and Y. Zhuravleva, "The pathogenesis of end-stage renal disease from the standpoint of the theory of general pathological processes of inflammation," International Journal of …, 2021. [Online]. Available: mdpi.com
Z. K. Abbas, et al., "Immunological biomarkers and their role in the diagnosis and prognosis of leishmaniasis: A case–control study," Tropical Parasitology, vol. 15, no. 1, pp. 33–41, 2025.
E. Gusev and A. Sarapultsev, "Atherosclerosis and inflammation: Insights from the theory of general pathological processes," International Journal of Molecular Sciences, 2023. [Online]. Available: mdpi.com
J. Kussini, S. Mühlenbein, D. Didona, et al., "Cutaneous reactions to vaccination," JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2025. [Online]. Available: wiley.com
E. Gusev and Y. Zhuravleva, "Inflammation: A new look at an old problem," International Journal of Molecular Sciences, 2022. [Online]. Available: mdpi.com
E. Gusev, A. Sarapultsev, and L. Solomatina, "Lessons From the COVID-19 Pandemic," Int. J. Mol. Sci., 2022. [Online]. Available: academia.edu
W. C. Marsch, "Disorders of Hemostasis," Braun-Falco’s Dermatology, 2022. [Online]. Available: [HTML]
C. Grunwald, A. Krętowska-Grunwald, E. Adamska-Patruno, J. Kochanowicz, et al., "The Role of Selected Interleukins in the Development and Progression of Multiple Sclerosis—A Systematic Review," 2024. [Online]. Available: ncbi.nlm.nih.gov
S. Rodríguez Murúa and M. F. Farez, "The immune response in multiple sclerosis," Mechanisms of Disease, vol. 2022, 2022. [Online]. Available: [HTML]
S. Haase and R. A. Linker, "Inflammation in multiple sclerosis," Therapeutic Advances in Neurological Disorders, vol. 14, 2021. [Online]. Available: sagepub.com
F. L. J. Almohaisen, et al., "Cytokines' Impact on Postpartum Hair Loss After First C-Section in Women 28-38," Indonesian Journal on Health Science and Medicine, vol. 2, no. 2, pp. 10–21070, 2025.
Z. Khan, S. Mehan, G. D. Gupta, and A. S. Narula, "Immune system dysregulation in the progression of multiple sclerosis: molecular insights and therapeutic implications," Neuroscience, 2024. [Online]. Available: researchgate.net
N. N. Arimitsu, A. Witkowska, A. Ohashi, and C. Miyabe, "Chemokines as therapeutic targets for multiple sclerosis: a spatial and chronological perspective," Frontiers in …, 2025. [Online]. Available: frontiersin.org
S. Akhter, F. M. Tasnin, M. N. Islam, and A. Rauf, "Role of Th17 and IL-17 Cytokines on Inflammatory and Auto-immune Diseases," Current …, 2023. [Online]. Available: [HTML]
M. A. Dias de Sousa, C. S. Desidério, J. da Silva Catarino, et al., "Role of Cytokines, Chemokines and IFN-γ+ IL-17+ Double-Positive CD4+ T Cells in Patients with Multiple Sclerosis," Biomedicines, 2022. [Online]. Available: mdpi.com
N. Garg, E. J. Padron, K. W. Rammohan, et al., "Bruton's tyrosine kinase inhibitors: The next frontier of B-cell-targeted therapies for cancer, autoimmune disorders, and multiple sclerosis," Journal of Clinical, vol. 2022. [Online]. Available: mdpi.com
M. Iglesias, A. Arun, M. Chicco, B. Lam et al., "Type-I Interferons Inhibit Interleukin-10 Signaling and Favor Type 1 Diabetes Development in Nonobese Diabetic Mice," 2018. [Online]. Available: ncbi.nlm.nih.gov
W. Li, W. Tan, J. L. Zou, Y. He, and S. Yoshida, "Role of interferons in diabetic retinopathy," Journal of Diabetes, vol. 2021. [Online]. Available: nih.gov
M. Benucci, P. Bernardini, C. Coccia, R. De Luca et al., "JAK inhibitors and autoimmune rheumatic diseases," Autoimmunity, vol. 2023. [Online]. Available: sciencedirect.com
H. Jiang, Y. Li, M. Shen, Y. Liang, Y. Qian, and H. Dai, "Interferon‐α promotes MHC I antigen presentation of islet β cells through STAT1‐IRF7 pathway in type 1 diabetes," 2022. [Online]. Available: wiley.com
T. Efferth and F. Oesch, "The immunosuppressive activity of artemisinin‐type drugs towards inflammatory and autoimmune diseases," Medicinal Research Reviews, 2021. [Online]. Available: wiley.com
M. Waibel, J. M. Wentworth, and M. So, "Baricitinib and β-cell function in patients with new-onset type 1 diabetes," New England Journal of Medicine, vol. 2023. [Online]. Available: nejm.org
M. Waibel, H. E. Thomas, J. M. Wentworth, J. J. Couper et al., "Investigating the efficacy of baricitinib in new onset type 1 diabetes mellitus (BANDIT)—study protocol for a phase 2, randomized, placebo controlled trial," Trials, vol. 23, no. 1, 2022. [Online]. Available: springer.com
P. Kong, Z. Y. Cui, X. F. Huang, and D. D. Zhang, "Inflammation and atherosclerosis: signaling pathways and therapeutic intervention," Signal Transduction and Targeted Therapy, vol. 7, no. 1, 2022. [Online]. Available: nature.com
J. R. N. Lemos, K. Hirani, and M. von Herrath, "Immunological and virological triggers of type 1 diabetes: insights and implications," Frontiers in Immunology, 2024. [Online]. Available: frontiersin.org
X. Lu, Q. Xie, X. Pan, R. Zhang, and X. Zhang, "Type 2 diabetes mellitus in adults: pathogenesis, prevention and therapy," Signal Transduction, vol. 2024. [Online]. Available: nature.com
K. Nagata and C. Nishiyama, "IL-10 in mast cell-mediated immune responses: anti-inflammatory and proinflammatory roles," International Journal of Molecular Sciences, 2021. [Online]. Available: mdpi.com
D. Lateef, N. Nasser, and O. Mohsein, "The relationships between Aplein, Vaspin and thyroid hormone levels in obese diabetic and non-diabetic women," Journal of Experimental and Clinical Medicine, vol. 41, no. 2, pp. 239–245, 2024.
L. Jimbu, O. Mesaros, A. Neaga, A. M. Nanut et al., "The potential advantage of targeting both PD-L1/PD-L2/PD-1 and IL-10–IL-10R pathways in acute myeloid leukemia," Pharmaceuticals, vol. 14, no. 2, 2021. [Online]. Available: mdpi.com
H. Islam, T. C. Chamberlain, A. L. Mui, and J. P. Little, "Elevated interleukin-10 levels in COVID-19: potentiation of pro-inflammatory responses or impaired anti-inflammatory action?," Frontiers in Immunology, 2021. [Online]. Available: frontiersin.org
L. A. González, F. Melo-González, V. P. Sebastián et al., "Characterization of the Anti-Inflammatory Capacity of IL-10-Producing Neutrophils in Response to Streptococcus pneumoniae Infection," Frontiers in Immunology, vol. 12, 2021. [Online]. Available: frontiersin.org
M. Orecchioni, D. Wolf, V. Suryawanshi et al., "Deleting interleukin-10 from myeloid cells exacerbates atherosclerosis in Apoe−/− mice," Cellular and Molecular Immunology, vol. 2023. [Online]. Available: springer.com
H. Islam, H. Neudorf, A. L. Mui et al., "Interpreting 'anti‐inflammatory' cytokine responses to exercise: focus on interleukin‐10," The Journal of Physiology, vol. 599, no. 10, pp. 2671–2686, 2021. [Online]. Available: wiley.com
I. Martinez-Espinosa, J. A. Serrato, and B. Ortiz-Quintero, "Role of IL-10-producing natural killer cells in the regulatory mechanisms of inflammation during systemic infection," Biomolecules, 2021. [Online]. Available: mdpi.com
A. N. Faisal, A. M. Abbas, and O. A. Mohsein, "Histological and cytokine-based biomarkers in the early diagnosis of cancer," Indonesian Journal on Health Science and Medicine, vol. 2, no. 2, pp. 10–21070, 2025.
G. M. Leone, K. Mangano, M. C. Petralia, and F. Nicoletti, "Past, present and (foreseeable) future of biological anti-TNF alpha therapy," Journal of Clinical …, 2023. [Online]. Available: mdpi.com
H. Zhang, N. Shi, Z. Diao, Y. Chen et al., "Therapeutic potential of TNFα inhibitors in chronic inflammatory disorders: Past and future," Genes & Diseases, 2021. [Online]. Available: sciencedirect.com
M. Kumar, S. Murugesan, N. Ibrahim, and M. Elawad, "Predictive biomarkers for anti-TNF alpha therapy in IBD patients," Journal of Translational Medicine, vol. 2024. [Online]. Available: springer.com
V. Andretto, S. Dusi, S. Zilio, M. Repellin, D. Kryza et al., "Tackling TNF-α in autoinflammatory disorders and autoimmune diseases: from conventional to cutting edge in biologics and RNA-based nanomedicines," Advanced Drug Delivery Reviews, vol. 2023. [Online]. Available: sciencedirect.com
G. Evangelatos, G. Bamias, G. D. Kitas, G. Kollias et al., "The second decade of anti-TNF-a therapy in clinical practice: new lessons and future directions in the COVID-19 era," Rheumatology, vol. 2022. [Online]. Available: springer.com
P. Eder, A. Zielińska, and J. Karczewski, "How could nanobiotechnology improve treatment outcomes of anti-TNF-α therapy in inflammatory bowel disease? Current knowledge, future directions," Journal of …, vol. XX, no. YY, pp. ZZ–ZZ, 2021. [Online]. Available: springer.com
S. D. Abubakar, S. A. Ihim, A. Farshchi et al., "The role of TNF-α and anti-TNF-α agents in the immunopathogenesis and management of immune dysregulation in primary immunodeficiency diseases," 2022. [Online]. Available: Taylor & Francis
A. Lorenzo-Vizcaya and D. A. Isenberg, "The use of anti-TNF-alpha therapies for patients with systemic lupus erythematosus. Where are we now?," Expert Opinion on Biological Therapy, vol. 21, no. 1, pp. 1–10, 2021. [Online]. Available: ucl.ac.uk
A. A. Zarrin, K. Bao, P. Lupardus, and D. Vucic, "Kinase inhibition in autoimmunity and inflammation," 2021. [Online]. Available: ncbi.nlm.nih.gov
G. H. Liu, T. Chen, X. Zhang, X. L. Ma et al., "Small molecule inhibitors targeting the cancers," MedComm, 2022. [Online]. Available: wiley.com
C. C. Ayala-Aguilera and T. Valero, "Small molecule kinase inhibitor drugs (1995–2021): medical indication, pharmacology, and synthesis," Journal of Medicinal Chemistry, vol. 64, no. X, pp. Y–Z, 2021.
M. Attwood, D. Fabbro, A. V. Sokolov, S. Knapp et al., "Trends in kinase drug discovery: targets, indications and inhibitor design," Nature Reviews Drug Discovery, vol. 20, no. 1, pp. 1–15, 2021.
R. Offringa, L. Kötzner, B. Huck, and K. Urbahns, "The expanding role for small molecules in immuno-oncology," Nature Reviews Drug Discovery, vol. 21, no. 8, pp. 579–596, 2022.
Z. Xie, X. Yang, Y. Duan, J. Han et al., "Small-molecule kinase inhibitors for the treatment of nononcologic diseases," Journal of Medicinal Chemistry, vol. 64, no. 1, pp. 1–20, 2021.
L. Fu, S. Chen, G. He, Y. Chen, and B. Liu, "Targeting extracellular signal-regulated protein kinase 1/2 (ERK1/2) in cancer: an update on pharmacological small-molecule inhibitors," Journal of Medicinal Chemistry, vol. 2022.
K. K. Bhanumathy, A. Balagopal, F. S. Vizeacoumar et al., "Protein tyrosine kinases: their roles and their targeting in leukemia," Cancers, 2021.
F. Ren, A. Aliper, J. Chen, H. Zhao, S. Rao, C. Kuppe et al., "A small-molecule TNIK inhibitor targets fibrosis in preclinical and clinical models," Nature, 2025.
C. Gabay and I. B. McInnes, "The biological and clinical importance of the 'new generation' cytokines in rheumatic diseases," 2009.
N. Kondo, T. Kuroda, and D. Kobayashi, "Cytokine networks in the pathogenesis of rheumatoid arthritis," International Journal of Molecular Sciences, vol. 2021, 2021.
S. Yang, M. Zhao, and S. Jia, "Macrophage: Key player in the pathogenesis of autoimmune diseases," Frontiers in Immunology, 2023.
Q. Jiang, G. Yang, F. Xiao, J. Xie, S. Wang, and L. Lu, "Role of Th22 cells in the pathogenesis of autoimmune diseases," Frontiers in Immunology, vol. 12, 2021.
X. Fu, H. Liu, G. Huang, and S. S. Dai, "The emerging role of neutrophils in autoimmune‐associated disorders: effector, predictor, and therapeutic targets," MedComm, 2021.
M. D. Chávez and H. M. Tse, "Targeting mitochondrial-derived reactive oxygen species in T cell-mediated autoimmune diseases," Frontiers in Immunology, 2021.
J. Zhao, Q. Lu, Y. Liu, Z. Shi, L. Hu, and Z. Zeng, "Th17 cells in inflammatory bowel disease: cytokines, plasticity, and therapies," Journal of …, 2021.
M. J. Barrera, S. Aguilera, I. Castro, P. Carvajal, and D. Jara, "Dysfunctional mitochondria as critical players in the inflammation of autoimmune diseases: Potential role in Sjögren's syndrome," Autoimmunity, vol. 54, no. 1, pp. 1–12, 2021.
L. Broderick and H. M. Hoffman, "IL-1 and autoinflammatory disease: biology, pathogenesis and therapeutic targeting," Nature Reviews Rheumatology, 2022.
M. Ramaswamy, R. Tummala, K. Streicher et al., "The pathogenesis, molecular mechanisms, and therapeutic potential of the interferon pathway in systemic lupus erythematosus and other autoimmune diseases," International Journal of …, 2021.
J. G. Sathish, S. Sethu, M. C. Bielsky, L. de Haan et al., "Challenges and approaches for the development of safer immunomodulatory biologics," 2013.
S. Patil, V. Gs, G. S. Sarode, and S. C. Sarode, "Exploring the role of immunotherapeutic drugs in autoimmune diseases: a comprehensive review," Journal of Oral Biology, vol. 2021.
J. P. Patel, N. K. K. Srinivasa, A. Gande, M. Anusha, and H. Dar, "The role of biologics in rheumatoid arthritis: a narrative review," Cureus, 2023.
F. F. Konen, N. Möhn, T. Witte, M. Schefzyk, and M. Wiestler, "Treatment of autoimmunity: the impact of disease-modifying therapies in multiple sclerosis and comorbid autoimmune disorders," Autoimmunity, vol. 2023.
S. Akiyama and T. G. Cotter, "Risk of hepatitis B virus reactivation in patients with autoimmune diseases undergoing non-tumor necrosis factor-targeted biologics," World Journal of …, 2021.
R. Giacomelli, A. Afeltra, E. Bartoloni, O. Berardicurti et al., "The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and Experts' Consensus," Autoimmunity, vol. 2021.
D. S. W. Lee, O. L. Rojas, and J. L. Gommerman, "B cell depletion therapies in autoimmune disease: advances and mechanistic insights," Nature Reviews Drug Discovery, 2021.
Y. Tanaka, "Recent progress in treatments of rheumatoid arthritis: an overview of developments in biologics and small molecules, and remaining unmet needs," Rheumatology, 2021.
H. I. Ahmad, A. Jabbar, N. Mushtaq, and Z. Javed, "Immune tolerance vs. immune resistance: the interaction between host and pathogens in infectious diseases," Frontiers in Veterinary Science, vol. 2022.
M. Noack and P. Miossec, "Importance of lymphocyte–stromal cell interactions in autoimmune and inflammatory rheumatic diseases," Nature Reviews Rheumatology, 2021.
C. H. Kim, "Complex regulatory effects of gut microbial short-chain fatty acids on immune tolerance and autoimmunity," Cellular & Molecular Immunology, 2023.
Y. Peng, M. Zhou, H. Yang, R. Qu, and Y. Qiu, "Regulatory mechanism of M1/M2 macrophage polarization in the development of autoimmune diseases," Mediators of …, 2023.
S. A. Ihim, S. D. Abubakar, Z. Zian, and T. Sasaki, "Interleukin-18 cytokine in immunity, inflammation, and autoimmunity: Biological role in induction, regulation, and treatment," Frontiers in …, 2022.
S. Cerboni, U. Gehrmann, S. Preite, and S. Mitra, "Cytokine‐regulated Th17 plasticity in human health and diseases," Immunology, 2021.
A. S. Perera Molligoda Arachchige, "Human NK cells: From development to effector functions," Innate Immunity, 2021.
C. Huang and J. Bi, "Expression regulation and function of T-Bet in NK cells," Frontiers in Immunology, 2021.
J. Bi, C. Cheng, C. Zheng, C. Huang, X. Zheng, and X. Wan, "TIPE2 is a checkpoint of natural killer cell maturation and antitumor immunity," Science, 2021.
Q. Shang, X. Yu, Q. Sun, H. Li et al., "Polysaccharides regulate Th1/Th2 balance: a new strategy for tumor immunotherapy," Biomedicine & Pharmacotherapy, 2024.
E. J. Boll, D. V. Lopez, M. Terne, and S. Hessing, "Human milk oligosaccharides differentially support gut barrier integrity and enhance Th1 and Th17 cell effector responses in vitro," Frontiers in …, 2024.
Copyright (c) 2025 Ayoob Murtadha Alshaikh Faqri, Adeeb Abdulally Abdulhussien, Lamia Jarallah Yaseen, Osama A. Mohsein
This work is licensed under a Creative Commons Attribution 4.0 International License.
